Global Blood Therapeutics, Inc. (GBT): Stock Offering News

GBT – Proposing 3.5 mln share common stock offering.


Key Facts Surrounding This News Item


  • GBT had a POWR Rating of B (Buy) coming into today.
  • GBT was -1.57% below its 10-Day Moving Average coming into today.
  • GBT was -1.82% below its 20-Day Moving Average coming into today.
  • GBT was 8.60% above its 50-Day Moving Average coming into today.
  • GBT was 28.84% above its 100-Day Moving Average coming into today.
  • GBT was 59.95% above its 200-Day Moving Average coming into today.
  • GBT had returned +52.86% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Global Blood Therapeutics, Inc. (GBT)


Global Blood Therapeutics is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. The company was founded in 2012 and is based in San Francisco, California. View our full GBT ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

GBT at a Glance

GBT Current POWR Rating™
Overall POWR Rating™
GBT Current Price $39.75 3.99%
More GBT Ratings, Data, and News

GBT Price Reaction

The day of this event (Mar. 8, 2018)
GBT Closing Price$56.90 5.40%
GBT Volume810,200
22.29% from avg
Leading up to this event
GBT 1-mo return1.95%
After this event
GBT 1-day return5.25%
GBT 3-day return11.91%
GBT 5-day return10.57%

GBT Price Chart



More Global Blood Therapeutics, Inc. (GBT) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GBT News
Page generated in 1.1193 seconds.